Premenstrual Dysphoric Disorder is a severe condition affecting millions of women worldwide, yet it remains underdiagnosed and misunderstood. Oxford University estimates 1.6% of women globally meet the strict PMDD criteria, while up to 3.2% (>60m individuals) receive provisional PMDD diagnoses. True prevalence is expected to be even higher due to underdiagnosis.
PMDD can cause debilitating symptoms:
“PMDD is associated with significant impairment in daily life and increased suicide risk, underscoring the urgent need for awareness and treatment options.”
At Period Pill, we’re dedicated to increase awareness. Together, we can create a world that prioritizes menstrual health.
Read the full publication here: https://lnkd.in/ezPtfXvj